Autism
Autism
Autism
16p11.2
Figure C-5 Chromosomal microarray analysis of a 16p11.2 deletion in a patient with autism spectrum disorder. Chromosome 16 ideogram with probe coverage
(dots) along the length of the chromosome. The log2 ratio scale is shown on the left; probes with a normal ratio are shown in black, whereas probes with a ratio suggestive
of either a loss or gain are shown in green and red, respectively. The deleted region is highlighted (pink) in the expanded region of the figure below. The red bar corresponds
to the deleted region (≈600 kb), which is flanked by paired segmental duplications that mediate the deletion. See Sources & Acknowledgments.
from a healthy parent than the microdeletion. Thus the dupli- INHERITANCE RISK
cation probably increases susceptibility to delays or psychiat-
16p11.2 deletion is usually de novo but can be inherited from
ric disorders with low penetrance.
a parent. When de novo, the recurrence risk for the parents is
Array CGH is a powerful tool that has identified the etiol-
less than 5%, taking into account the risk for gonadal mosa-
ogy of developmental delay/intellectual disability, develop-
icism. If one parent also carries the deletion, recurrence risk
mental disorders such as ASD, and/or multiple congenital
for the deletion is 50% for each subsequent pregnancy. There-
anomalies in up to 20% of individuals tested. In general, the
fore, in order to provide appropriate genetic counseling, it is
technology has changed the way that medical geneticists prac-
crucial to perform parental studies when a 16p11.2 abnormal-
tice (see Chapters 5 and 6). However, uncertainty regarding
ity is diagnosed in a child. However, due to incomplete pen-
results is an ever-present dilemma; variants of uncertain sig-
etrance, a child who inherits the deletion may not be affected
nificance (VUSs; see Chapter 16) abound. Several recommen-
with the same features as his or her sibling and may exhibit
dations have arisen to help determine the pathogenicity of
normal intelligence and behavior. Alternatively, an affected
results. The size and dosage effect of the CNV is important;
child may have more significant intellectual disability, autistic
loss of genomic material and large variations are more detri-
features, and/or health concerns.
mental than gains and small changes, in general. However,
small CNVs in a gene-rich area can cause phenotypic mani-
festations, whereas large CNVs in a gene-poor region may not.
Parents of a child with a VUS should have array or FISH
testing to determine if a CNV is inherited or de novo; an REFERENCES
inherited VUS from a phenotypically normal parent is histori-
cally considered less likely to be pathogenic. However, as with McCarthy S, Makarov V, Kirov G, et al: Microduplications of 16p11.2 are associated
16p11.2 microdeletion and microduplication syndromes, with schizophrenia, Nat Genet 41:1223–1227, 2009.
incomplete penetrance can exist with many CNVs; therefore Miller DT, Nasir R, Sobeih MM, et al: 16p11.2 Microdeletion. Available from: http://
an inherited VUS cannot be ruled benign based only on this www.ncbi.nlm.nih.gov/books/NBK11167/.
Simons VIP Consortium: Simons Variation in Individuals Project (Simons VIP): a
information. genetics-first approach to studying autism spectrum and related neurodevelop-
Because of the potential for ambiguous results, providing mental disorders, Neuron 73:1063–1067, 2012.
genetic counseling to a family regarding the possible implica- Unique, the Rare Chromosomal Disorder Support Group. Available from: http://
tions of testing both before and after array CGH testing is www.rarechromo.org.
beneficial. Weiss LA, Shen Y, Korn JM, et al: Association between microdeletion and micro-
duplication at 16p11.2 and autism, N Engl J Med 358:667–675, 2008.
Management
Because of the higher prevalence of developmental delay/
intellectual disability and ASD features in individuals with
16p11.2 microdeletion, referral to a developmental pediatri-
cian or clinical psychologist is recommended for developmen-
tal assessment and placement in appropriate early intervention
services, such as physical, occupational, and speech therapies.
Social, behavioral, and educational interventions are also
available for children with ASDs. An echocardiogram and/or
electrocardiogram should be considered to look for aortic
valve or other structural heart anomalies, and referral to a
pediatric neurologist should be made if there is suspicion of
seizure activity. Weight management and nutritional support
should be provided because of the increased risk for obesity.